JW Shinyak Corporation (KOSDAQ:067290)

South Korea flag South Korea · Delayed Price · Currency is KRW
2,065.00
-15.00 (-0.72%)
At close: Mar 6, 2026
52.37%
Market Cap 109.23B
Revenue (ttm) 76.02B
Net Income (ttm) 10.16B
Shares Out 55.87M
EPS (ttm) 175.31
PE Ratio 11.15
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 733,766
Average Volume 2,733,247
Open 2,100.00
Previous Close 2,080.00
Day's Range 1,985.00 - 2,145.00
52-Week Range 1,220.00 - 2,670.00
Beta 0.79
RSI 47.43
Earnings Date Mar 18, 2026

About JW Shinyak

JW Shinyak Corporation engages in the research, development, production, and sale of medicines and medical supplies in South Korea. It offers pharmaceutical products in the areas of dermatology, urology, pediatrics, otolaryngology, etc.; and cardiovascular, gastrointestinal, urinary, NSAIDs, antibiotics, anti-fungal, anti-viral, respiratory, antihistamines, steroid hormone, anti-obesity, and other products, as well as eye drops, and antitussives and expectorants. The company also develops prostate cancer treatment, liver cancer treatment, rheum... [Read more]

Industry Orthopedic, Prosthetic, and Surgical Appliances and Supplies
Founded 1981
Employees 183
Stock Exchange KOSDAQ
Ticker Symbol 067290
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.